Read on Twitter
Cochrane Review states:
'We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
'We found insufficient evidence to determine the efficacy or safety of hormonal treatment approaches for transgender women in transition. This lack of studies shows a gap between current clinical practice and clinical research.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
Cochrane Review:
'Our review found no RCTs that looked at whether hormone therapies are effective and safe when used to help transgender women to transition.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
'Our review found no RCTs that looked at whether hormone therapies are effective and safe when used to help transgender women to transition.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
Cochrane Review:
'This systematic review has shown that well‐designed, sufficiently robust randomised controlled trials (RCTs) and controlled‐cohort studies do not exist'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
'This systematic review has shown that well‐designed, sufficiently robust randomised controlled trials (RCTs) and controlled‐cohort studies do not exist'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
Cochrane Review:
'We excluded all 12 of the full‐text articles that we had assessed for eligibility, either because they used an ineligible comparator or because they used an ineligible study design.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
'We excluded all 12 of the full‐text articles that we had assessed for eligibility, either because they used an ineligible comparator or because they used an ineligible study design.'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
Cochrane Review:
'Despite more than four decades of ongoing efforts to improve the quality of hormone therapy for women [sic] in transition, we found that no RCTs or suitable cohort studies have yet been conducted...'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
'Despite more than four decades of ongoing efforts to improve the quality of hormone therapy for women [sic] in transition, we found that no RCTs or suitable cohort studies have yet been conducted...'
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
FiLiA hopes that organisations supporting the use of medical interventions for a diagnosis of gender dysphoria are being transparent about the data (or lack of) @stonewalluk @Mermaids_Gender @TaviAndPort and others
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
Universal Declaration on Bioethics and Human Rights
'Any preventive, diagnostic and therapeutic medical intervention is 𝗼𝗻𝗹𝘆 to be carried out with the prior, free and 𝗶𝗻𝗳𝗼𝗿𝗺𝗲𝗱 consent of the person concerned, 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗮𝗱𝗲𝗾𝘂𝗮𝘁𝗲 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻'
'Any preventive, diagnostic and therapeutic medical intervention is 𝗼𝗻𝗹𝘆 to be carried out with the prior, free and 𝗶𝗻𝗳𝗼𝗿𝗺𝗲𝗱 consent of the person concerned, 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗮𝗱𝗲𝗾𝘂𝗮𝘁𝗲 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻'
Those with gender dysphoria are not a cohort of people to be used by organisations with vested interests in forwarding their own political agendas and making a profit.
That would be transphobic.
FiLiA is anti-transphobia
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
That would be transphobic.
FiLiA is anti-transphobia
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013138.pub2/full
